$14.630
-1.091 (-7.46%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy BlossomHill Therapeutics Inc Stock?
BlossomHill Therapeutics, Inc. is a good buy right now due to its recent FDA Fast Track designation for BH-30643, which has shown a 45% objective response rate in clinical trials. The current price is $14.63, significantly lower than the analyst price target of $40, indicating substantial upside potential. However, the company is currently facing a risk with a negative net income of -$23,758,000 in Q2 2026, which investors should monitor closely.
BLSM stock price ended at $14.63 on Friday, after losing -7.46%
BlossomHill Therapeutics Inc (BLSM) last closed at $14.63, losing -7.46%. These facts feed the 1-day and 1-week BLSM price prediction above.
Forecast Drivers
BlossomHill Therapeutics Inc (BLSM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Seasonality analysis for BLSM
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.